Proton Beam Therapy and Hypofractionation in the Treatment of Cancer

2/4/22, 5:00 PM
Other/Outros

Description

In recent years, the demand for proton beam therapy – a specialised form of radiotherapy – has surged, positioning the UK as a key provider of this advanced treatment. In contrast to conventional radiotherapy using X-ray beams, proton beam therapy delivers beams of protons which are more targeted to reduce damage to peripheral tissue and organs. In its simplest form, its high precision and ability to stop the beam at a defined point means that it can dramatically reduce long-term side effects in some cases.

Join Dr Sarah Harris, Professor Roger Taylor, and John Pettingell, for an exciting and informative webinar on the evolving world of proton beam therapy on Friday 4th February at 2:00 pm (GMT).

John Pettingell, Chief Physicist & Head of Radiotherapy at the Rutherford Cancer Centres will introduce proton beam therapy, with an overview of how this leading cancer treatment works and will explore some of the reasons for choosing proton beam therapy as a treatment option.

Dr Sarah Harris will then discuss the advancements in proton beam therapy, including hypofractionation treatment for breast and prostate cancers, opening the possibilities for quicker and easier treatment options for patients and clinicians.

Professor Roger Taylor will finish by exploring where proton beam therapy can potentially make a difference to treatment quality in terms of sparing organs at risk, and why proton beam therapy can be the preferred pathway for specific body-sites.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Proton Beam Therapy and Hypofractionation in the Treatment of Cancer

Inglês

 

Speakers

Sarah Harris, Roger Taylor, John Pettingell